Acting under an existing trade deal between the UK and Canada, the medicines regulators in these two regions have expanded their present approach of recognizing good manufacturing practice inspection results. This now includes inspections that are conducted in countries outside their respective jurisdictions for human and veterinary finished products.
The expanded scope of the Canada-United Kingdom Trade Continuity Agreement (CUK TCA) in relation to extra-jurisdictional inspection outcomes came into...